Connect with us

Technology

4D Printing In Healthcare Market size is set to grow by USD 110.057 thousand from 2024-2028, Increased demand for personalized or customized medical devices to boost the market growth, Technavio

Published

2 years ago

on

NEW YORK, July 31, 2024 /PRNewswire/ — The global 4D printing in healthcare market size is estimated to grow by USD 110.057 thousand from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 44.82% during the forecast period. Increased demand for personalized or customized medical devices is driving market growth, with a trend towards emerging technological advances and applications of 4D printing in medical devices. However, high initial setup cost of 4d printing facilities poses a challenge. Key market players include 3D Systems Corp., Dassault Systemes SE, Desktop Metal Inc., EnvisionTEC GmBH, EOS GmbH, MATERIALISE NV, Organovo Holdings Inc., Otto GmbH and Co. KG, Poietis, and Stratasys Ltd..

Get a detailed analysis on regions, market segments, customer landscape, and companies – Click for the snapshot of this report

Forecast period

2024-2028

Base Year

2023

Historic Data

2017 – 2021

Segment Covered

Application (Implants, Medical devices, and Simulating and training), Component (Software and services, Equipment, and Programmable materials), and Geography (North America, Europe, Asia, and Rest of World (ROW))

Region Covered

North America, Europe, Asia, and Rest of World (ROW)

Key companies profiled

3D Systems Corp., Dassault Systemes SE, Desktop Metal Inc., EnvisionTEC GmBH, EOS GmbH, MATERIALISE NV, Organovo Holdings Inc., Otto GmbH and Co. KG, Poietis, and Stratasys Ltd.

Key Market Trends Fueling Growth

The healthcare industry is witnessing significant advancements in 4D printing technology, which is revolutionizing the production of medical devices. These technological strides have led to increased printer production speed, enhancing the volume capabilities of 4D systems. The benefits of 4D printing extend beyond speed, as it also reduces material waste and capital equipment expenditure, and decreases reliance on milling centers. In the dental sector, 4D printing offers higher precision and efficiency than competitive systems. For instance, Stratasys Ltd.’s acquisition of Origin in 2021 for mass production of additive-manufactured products underscores the industry’s focus on this technology. Furthermore, ongoing R&D efforts aim to develop new combinations of 4D printing materials and improve existing ones, expanding its applications and reducing costs. Notable materials include UV Silicone 60A MG, a biocompatible, bio-inert, non-biodegradable liquid silicone rubber, and HT PCL MG, a biodegradable thermoplastic polyester. EnvisionTEC’s introduction of the affordable E-OrthoShape material for 3D printing orthodontic models is another example of innovation in this field. Advancements in imaging modalities enable the creation of customized anatomical models with greater precision, further fueling the growth of 4D printing in healthcare. These developments are expected to create significant opportunities for the global 4D printing in healthcare market during the forecast period. 

The healthcare market is experiencing significant trends in 4D printing technology, which goes beyond traditional 3D printing by adding the fourth dimension of time. This innovation is revolutionizing medical equipment, drugs, and medical devices. 4D biomaterials are transforming dental crowns, smart bridges, surgical templates, aligners, and orthodontic braces, offering customized solutions. Technological developments in 4D printing are impacting various industries, including healthcare. Medical implants, biocompatibility, and biomedical splints are benefiting from this technology. Heart constructs, drug delivery systems, and even organ transplants are under development. 3D Systems is leading the investment in this field, with smart, programmable materials set to disrupt conventional manufacturing methods. The healthcare services administration is exploring 4D printing for organ constructs to address organ shortages and organ rejection issues. The technology’s potential extends to smart materials for heart valves, stents, and other medical devices. The integration of 4D printing technology in middle-income countries is expected to boost the healthcare market. Stereolithography and Fusion Deposition Modeling are popular 4D printing methods, with software and services supporting the design process. The automotive production and aerospace engineering industries have already embraced 4D printing, and healthcare is poised to follow suit. 

Discover 360° analysis of this market. For complete information, schedule your consultation- Book Here!

Market Challenges

The 4D printing market in healthcare faces significant challenges due to high capital costs. Expensive equipment, such as high-end additive manufacturing printers, and outsourced print service contracts contribute to these costs. Additionally, proprietary raw materials sold by manufacturers at high profit margins and the need for trained personnel to ensure quality production add to the expenses. A clinical 4D printing lab requires ancillary staff for printing and the time taken to produce parts ranges from hours to days, limiting mass manufacturing viability. These factors hinder the widespread adoption of 4D printers, thereby impeding the growth of the global 4D printing in healthcare market.The healthcare market is exploring the potential of 4D printing, a technology that goes beyond traditional 3D printing by adding a fourth dimension of time and motion. This technology holds significant promise for various healthcare applications, particularly in orthodontics, where braces can be custom-made to adjust to a patient’s teeth as they grow. However, challenges exist in implementing this technology. Conventional manufacturing methods in industries like automotive production and aerospace engineering have vastly different requirements than healthcare. Smart, programmable materials are crucial for 4D printing in healthcare. These materials can change shape in response to specific conditions, such as body temperature or pH levels. Heart valves, stents, and organ constructs are potential applications, addressing issues like blood flow and organ transplants. Health Resources and Services Administration faces organ shortages, making 4D printed organ constructs a potential solution. However, challenges like organ rejection, biocompatibility, and reimbursement policies must be addressed. 3D Systems, a leading 3D printing company, is investing in 4D printing technology, focusing on biomedical splits, drug delivery, and implants. Stereolithography and Fusion Deposition Modeling are popular 3D printing techniques, but software and services for 4D printing are still in development. Surgical guides, medical research models, patient-specific implants, and artificial intelligence are other potential applications. Hospitals and clinics are exploring this technology, with Prismlab leading the way in 4D printing research.

For more insights on driver and challenges – Download a Sample Report

Segment Overview 

This 4D printing in healthcare market report extensively covers market segmentation by

Application 1.1 Implants1.2 Medical devices1.3 Simulating and trainingComponent 2.1 Software and services2.2 Equipment2.3 Programmable materialsGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Implants- Medical implants are artificial devices designed to replace or enhance biological structures for various medical conditions, including cardiovascular, orthopedic, neurological, and dental ailments. These implants can be made from materials like skin, bone, metal, plastic, or ceramic and can be permanent or temporary. Risks and complications include infection, surgical failure, and implant failure. The healthcare industry has seen significant advancements with the introduction of 4D printing technology, enabling stimuli-responsive 3D structures in medical implants. This technology allows implants to change shape between programmed configurations, reversibly. The rising prevalence of chronic diseases, particularly among the aging population, is driving the demand for medical implants, leading to the growth of the 4D printing in healthcare market. Additionally, the increasing trend of tooth loss, particularly in the US, with about 3 million people currently having dental implants and an annual growth of 500,000, will further fuel the market expansion.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017 – 2021) – Download a Sample Report

Research Analysis

The 4D printing market in healthcare is revolutionizing the industry by enabling the creation of medical equipment, drugs, and devices with unique, time-dependent functions. This technology goes beyond traditional 3D printing by incorporating the fourth dimension of time, making medical innovations more dynamic and responsive to specific patient needs. Technological developments in 4D printing have expanded its applications in healthcare, from medical devices like dental crowns, smart bridges, surgical templates, aligners, and orthodontic braces, to advanced areas such as drug delivery systems and tissue engineering. 4D biomaterials, programmable materials, and design services are at the forefront of this innovation. These materials can change shape, release drugs, or adapt to environmental conditions over time, offering significant advantages over conventional manufacturing methods. Beyond healthcare, industries like automotive production and aerospace engineering have also embraced 4D printing for their unique challenges. The potential for 4D printing in healthcare is vast, with investment continuing to fuel development activities in this exciting field. Heart valves, for example, could be designed to open and close in response to specific conditions, while smart stents could adjust to the unique needs of individual patients. The possibilities are endless, making 4D printing a game-changer in the healthcare sector.

Market Research Overview

The 4D printing market in healthcare is experiencing significant growth as this innovative technology offers new possibilities in medical equipment, drugs, and medical devices. Unlike traditional 3D printing, 4D printing uses smart, programmable materials that can change shape over time in response to external stimuli. This technology holds immense potential in healthcare, from dental crowns and orthodontic braces to surgical templates, aligners, and even heart constructs. Technological developments in 4D printing are driving innovation in medical research models, implants, and drug delivery systems. The technology’s potential applications extend beyond medical devices, with the possibility of creating smart bridges, organ constructs, and even organs for transplant. The healthcare market is investing heavily in 4D printing technology, with development activities focusing on biocompatibility, biomedical splits, and smart materials. The technology’s potential to address organ shortages and organ rejection is a significant draw, with healthcare services administration and hospitals and clinics showing strong interest. The 4D printing market is not limited to high-income countries; middle-income countries are also investing in this technology, driven by its potential to reduce costs and improve access to healthcare. Stereolithography and Fusion Deposition Modeling are common 4D printing techniques, while software and services are essential components of the 4D printing ecosystem. Reimbursement policies and artificial intelligence are also playing a role in the adoption of 4D printing technology, with the potential to revolutionize conventional manufacturing methods in industries such as automotive production and aerospace engineering. Prismlab and other companies are leading the way in 4D printing research and development.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

ApplicationImplantsMedical DevicesSimulating And TrainingComponentSoftware And ServicesEquipmentProgrammable MaterialsGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/4d-printing-in-healthcare-market-size-is-set-to-grow-by-usd-110-057-thousand-from-2024-2028–increased-demand-for-personalized-or-customized-medical-devices-to-boost-the-market-growth-technavio-302210050.html

SOURCE Technavio

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Ontario Superior Court Awards Over $170 Million in Damages to Mutual Fund Investors in Landmark Class Action Decision

Published

7 minutes ago

on

July 18, 2026

By

TORONTO, July 17, 2026 /PRNewswire/ — On July 16, 2026, Justice Markus Koehnen of the Ontario Superior Court of Justice ordered CI Mutual Funds Inc. and AIC Limited to pay Class Members damages and interest in excess of $170 million.

The Market Timing class action, commenced in 2006, alleged that certain mutual fund managers permitted sophisticated offshore hedge fund investors to engage in frequent trading in their funds, that substantially diluted the investment of long-term investors, including retail unitholders, many of whom were retirees.

Rochon Genova has represented the long-term investors since the inception of this case, including before the Supreme Court of Canada, on appeal from an earlier certification motion.  The Supreme Court certified the case in 2013. A subsequent case management order divided the trial into two phases: a trial in respect of liability, and a subsequent trial in respect of damages. The liability trial was held in February, March and June 2022.

On February 13, 2023, Justice Koehnen issued reasons for judgment in respect of the liability trial.  Justice Koehnen found that both CI and AIC breached their duty of care to prevent “market timing” in their funds. The liability decision, indexed as Fischer v. IG Investment, 2023 ONSC 915, is available here.

The damages trial was heard before Justice Koehnen between March 28 and May 16, 2025. Closing submissions were heard on July 30, August 6 and August 7, 2025. In total, Class Counsel spent 41 days in trial on liability (24 days) and damages (17 days). On June 16, 2026, Justice Markus Koehnen of the Superior Court of Justice issued reasons for judgment in respect of the damages trial.

The Court accepted the evidence of the Plaintiffs’ expert, Professor Eric Zitzewitz, and determined that the “Next Day NAV method” of calculating damages was the appropriate methodology to use, as it measures the specific harm that the time zone arbitrage at issue caused, harm referred to as dilution.

Justice Koehnen determined that the “profits method”, the method of calculating damages advocated for by CI’s expert, was not appropriate as it “measures the wrong thing”. The Court determined that on a balance of probabilities, the “prerequisites of using the profits method” had not been met.

Ultimately, with respect to CI, the Court awarded the Plaintiffs $60,480,000 in damages for the harm resulting from CI’s failure to take appropriate steps to prevent market timing by certain Identified Accounts.

The Court also awarded the Plaintiffs damages caused by specific Additional Accounts at CI that were identified by the Plaintiffs’ expert, Professor Zitzewitz, as having engaged in market timing that harmed the unit holders.

With respect to AIC, the Court awarded the Plaintiffs a total of $37,900,659 in damages, which includes damages caused by the Identified Accounts, and Additional Accounts at AIC that were identified by the Plaintiffs’ expert as having engaged in market timing. 

The Court determined the Plaintiffs are also entitled to pre-judgment interest in the amount of 2.8% per annum, to be applied to the damages figures set out above, in addition to costs against both Defendants.

Peter Jervis, a senior partner at Rochon Genova who led the prosecution of this case, stated: “The damages decision sends a clear message that those who fail to safeguard investors from harmful market practices will be held accountable. That this result was achieved after two decades of hard-fought litigation, is a testament to the perseverance of the Representative Plaintiffs and Class Counsel, and to the strength of our judicial system in delivering access to justice in complex cases.”

Joel Rochon, the Managing Partner of Rochon Genova added: “The decision is an important victory not only for the Class Members, but for the integrity of Canadian capital markets. Mutual funds are a cornerstone of the retirement savings of millions of everyday Canadians, and investors are entitled to expect that fund managers will protect them from practices that unfairly dilute the value of their investments.”

The Plaintiffs in this action were represented by Peter Jervis, Joel Rochon, Sarah Fiddes and Jessica Marshall.

For further updates, please visit Rochon Genova’s website here.

View original content:https://www.prnewswire.com/news-releases/ontario-superior-court-awards-over-170-million-in-damages-to-mutual-fund-investors-in-landmark-class-action-decision-302828857.html

SOURCE Rochon Genova

Continue Reading

Technology

Global Commercial Service Robot Shipments Leader KEENON Puts Humanoids to Work at WAIC 2026

Published

7 minutes ago

on

July 18, 2026

By

SHANGHAI, July 18, 2026 /PRNewswire/ — At WAIC 2026, KEENON Robotics is bringing humanoid and specialized service robots onto the same stage—not as competing concepts, but as complementary forms of embodied intelligence working across complete commercial service workflows.

According to IDC, KEENON ranked first worldwide in commercial service robot shipments in 2025, while maintaining its leadership in the global delivery robot market. IDC also sees the industry moving toward a more diversified, multi-form future, where different robot types are deployed according to the needs of specific tasks and environments. KEENON first propose such strategy and WAIC showcase brings that trend to life.

At the booth, the newly introduced hotel laundry scenario demonstrates this approach most clearly. Humanoid robots complete operational tasks such as loading and operating washing machines, retrieving clean laundry, and folding garments, while the DINERBOT T9 supports the wider delivery workflow. Together, they show how humanoid and specialized robots can divide responsibilities and collaborate within a real hotel operation.

Beyond the hotel workflow, KEENON applies the same role-based approach to food and retail service. Drawing on years of customer insight from restaurants and stores, XMAN-R1 takes on front-of-house tasks that combine interaction with object handling—from preparing drinks with NOWWA Coffee to responding to customer requests in dessert and retail settings. Rather than presenting isolated demonstrations, these scenarios show how KEENON is extending proven commercial service workflows into new humanoid capabilities, with every task performed autonomously and without teleoperation.

Through its “general-purpose humanoid + specialized service robot” strategy, KEENON is building a practical path for embodied intelligence: humanoids take on flexible operation and interaction tasks, while specialized robots continue to handle high-frequency delivery and cleaning. At WAIC 2026, KEENON is showing not just more robot forms, but a more complete model for commercial deployment.

With more than 100,000 service robots deployed worldwide across over 70 countries and regions, KEENON has been recognized by global renown brands across various sectors and widely deployed at major brands like Burger King, Buffalo Wild Wings, Hilton, BMW, Lego etc. From 10 to 20+ robots operating in single venues like Hotel Around Pyeongchang to a mixed fleet of 8 robots across 6 types at facilities like Shangri-La’s Trader Hotel, making it world-first intelligent hotel with both humanoid and service robot, KEENON delivers proven multi-robot efficiency.

SOURCE KEENON Robotics Co., Ltd.

Continue Reading

Technology

MDT Introduces TMR1370 Ultra-Low-Power Magnetic Switch IC Enabling More Than Two Years of Standby Operation in CGM Devices

Published

1 hour ago

on

July 18, 2026

By

— Next-Generation TMR Magnetic Switch with Ultra-Low 50nA Maximum Supply Current Expands MDT’s Proven CGM Sensor Portfolio

ZHANGJIAGANG, China, July 18, 2026 /PRNewswire/ — MultiDimension Technology Co., Ltd. (MDT), a leading supplier of magnetic sensors and a pioneer in Tunneling Magnetoresistance (TMR) technology, today introduced the TMR1370 ultra-low-power magnetic switch IC, the newest addition to MDT’s magnetic sensing portfolio for continuous glucose monitoring (CGM) devices. Building on the proven TMR1367, TMR1368, and TMR1369 family, the TMR1370 delivers significantly lower power consumption, enhanced voltage compatibility, and a smaller package to enable next-generation CGM systems with ultra-long standby life.

Optimized for battery-powered CGM devices, the TMR1370 features a maximum supply current of only 50nA, with approximately 30nA typical at a 3V supply. When combined with the magnetic wake-up mechanism widely adopted in CGM devices, the TMR1370 enables more than two years of standby operation, helping extend product shelf life while preserving battery capacity for continuous glucose monitoring after activation.

The TMR1370’s exceptional power efficiency is enabled by MDT’s proprietary TMR technology platform, which combines advanced magnetic sensor design, optimized device architecture, and proprietary wafer process technology to achieve high magnetic sensitivity together with ultra-low power consumption. Complementing MDT’s existing X-axis and Z-axis CGM magnetic switch portfolio, the TMR1370 gives system designers greater flexibility to optimize sensor orientation and mechanical layout for a wide variety of CGM architectures while enabling easy migration from previous-generation devices.

Key Features

Enables more than two years of standby operation in battery-powered CGM devices.50nA maximum supply current, approximately 30nA typical at 3V.Wide 1.8V to 4.0V operating-voltage range.Maximum operating point below 40 Gauss for reliable magnetic wake-up detection.X-axis magnetic sensing optimized for compact CGM designs.Miniature DFN5L package (1.6×1.6×0.5mm) for thinner and lighter wearable medical devices.Complements MDT’s proven X-axis and Z-axis CGM magnetic switch portfolio for flexible system design and simplified migration.

Samples of the TMR1370 are available through DigiKey and MDT’s online store at www.tmr-sensors.com. For volume pricing, delivery information, and technical specifications, contact MDT Global Sales at sales@dowayusa.com.

About MDT
MultiDimension Technology was founded in 2010 in Zhangjiagang, Jiangsu Province, China, with branch offices in Shenzhen, Chengdu, and Ningbo in China, Singapore, Tokyo, Japan, and San Jose, Calif., USA. MDT has developed a unique intellectual property portfolio, and its self-owned state-of-the-art TMR manufacturing facilities that can support volume production of high-performance, low-cost TMR magnetic sensors to satisfy the most demanding application needs. Led by its core management team of elite experts and veterans in magnetic sensor technology and engineering services, MDT is committed to creating added value for its customers and ensuring their success. For more information about MDT please visit http://www.multidimensiontech.com.

Media Contacts
MDT sales department, sales@dowayusa.com, sales@dowaytech.com
Tel: +1-650-275-2318 (US), +86-189-3612-1156 (China)

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/mdt-introduces-tmr1370-ultra-low-power-magnetic-switch-ic-enabling-more-than-two-years-of-standby-operation-in-cgm-devices-302828591.html

SOURCE MultiDimension Technology Co., Ltd.

Continue Reading

Trending